33293383|t|HIV-1 Vpr-Induced Proinflammatory Response and Apoptosis Are Mediated through the Sur1-Trpm4 Channel in Astrocytes.
33293383|a|Successful treatment of HIV-infected patients with combinational antiretroviral therapies (cART) can now prolong patients' lives to nearly normal life spans. However, the new challenge faced by many of those HIV-infected patients is chronic neuroinflammation and neurotoxicity that often leads to HIV-associated neurocognitive disorders (HAND). However, the mechanism of neuropathogenesis underlying HAND, especially in those who are under cART, is not well understood. HAND is typically characterized by HIV-mediated glial neuroinflammation and neurotoxicity. However, the severity of HAND does not always correlate with HIV-1 viral load but, rather, with the extent of glial activation, suggesting that other HIV-associated factors might contribute to HAND. HIV-1 viral protein R (Vpr) could be one of those viral factors because of its association with neuroinflammation and neurotoxicity. The objective of this study was to delineate the specific roles of HIV-1 infection and Vpr in the activation of neuroinflammation and neurotoxicity, and the possible relationships with the Sur1-Trpm4 channel that contributes to neuroinflammation and neuronal death. Here, we show that HIV-1 expression correlates with activation of proinflammatory markers (TLR4, TNF-alpha, and NF-kappaB) and the Sur1-Trpm4 channel in astrocytes of HIV-infected postmortem human and transgenic Tg26 mouse brain tissues. We further show that Vpr alone activates the same set of proinflammatory markers and Sur1 in a glioblastoma SNB19 cell line that is accompanied by apoptosis. The Sur1 inhibitor glibenclamide significantly reduced Vpr-induced apoptosis. Together, our data suggest that HIV-1 Vpr-induced proinflammatory response and apoptosis are mediated at least in part through the Sur1-Trpm4 channel in astrocytes.IMPORTANCE Effective antiretroviral therapies can now prolong patients' lives to nearly normal life span. The current challenge faced by many HIV-infected patients is chronic neuroinflammation and neurotoxicity that contributes to HIV-associated neurocognitive disorders (HAND). We show here that the expression of HIV-1 infection and Vpr correlates with the activation of proinflammatory markers (Toll-like receptor 4 [TLR4], tumor necrosis factor alpha [TNF-alpha], and NF-kappaB) and the sulfonylurea receptor 1 (Sur1)-transient receptor potential melastatin 4 (Trpm4) channel in astrocytes of brain tissues. We further show that an FDA-approved Sur1 inhibitory drug called glibenclamide significantly ameliorates apoptotic astrocytic cell death caused by HIV-1 Vpr, which could potentially open the possibility of repurposing glibenclamide for treating HAND.
33293383	0	5	HIV-1	Species	11676
33293383	6	9	Vpr	Gene	
33293383	18	33	Proinflammatory	Disease	
33293383	82	92	Sur1-Trpm4	Gene	6833;54795
33293383	140	152	HIV-infected	Disease	MESH:D015658
33293383	153	161	patients	Species	9606
33293383	229	237	patients	Species	9606
33293383	324	336	HIV-infected	Disease	MESH:D015658
33293383	337	345	patients	Species	9606
33293383	357	374	neuroinflammation	Disease	MESH:D000090862
33293383	379	392	neurotoxicity	Disease	MESH:D020258
33293383	413	416	HIV	Disease	MESH:D015658
33293383	428	452	neurocognitive disorders	Disease	MESH:D019965
33293383	454	458	HAND	Disease	MESH:D016263
33293383	516	520	HAND	Disease	MESH:D016263
33293383	586	590	HAND	Disease	MESH:D016263
33293383	621	624	HIV	Species	11676
33293383	640	657	neuroinflammation	Disease	MESH:D000090862
33293383	662	675	neurotoxicity	Disease	MESH:D020258
33293383	702	706	HAND	Disease	MESH:D016263
33293383	738	743	HIV-1	Species	11676
33293383	827	830	HIV	Species	11676
33293383	870	874	HAND	Disease	MESH:D016263
33293383	876	881	HIV-1	Species	11676
33293383	888	897	protein R	Gene	6947
33293383	899	902	Vpr	Gene	
33293383	972	989	neuroinflammation	Disease	MESH:D000090862
33293383	994	1007	neurotoxicity	Disease	MESH:D020258
33293383	1076	1091	HIV-1 infection	Disease	MESH:D015658
33293383	1096	1099	Vpr	Gene	
33293383	1121	1138	neuroinflammation	Disease	MESH:D000090862
33293383	1143	1156	neurotoxicity	Disease	MESH:D020258
33293383	1198	1208	Sur1-Trpm4	Gene	6833;54795
33293383	1237	1254	neuroinflammation	Disease	MESH:D000090862
33293383	1259	1273	neuronal death	Disease	MESH:D009410
33293383	1294	1299	HIV-1	Species	11676
33293383	1341	1356	proinflammatory	Disease	
33293383	1366	1370	TLR4	Gene	7099
33293383	1372	1381	TNF-alpha	Gene	7124
33293383	1387	1396	NF-kappaB	Gene	4790
33293383	1406	1416	Sur1-Trpm4	Gene	6833;54795
33293383	1442	1454	HIV-infected	Disease	MESH:D015658
33293383	1466	1471	human	Species	9606
33293383	1487	1491	Tg26	CellLine	CVCL:8806
33293383	1492	1497	mouse	Species	10090
33293383	1570	1585	proinflammatory	Disease	
33293383	1598	1602	Sur1	Gene	6833
33293383	1608	1620	glioblastoma	Disease	MESH:D005909
33293383	1621	1626	SNB19	CellLine	CVCL:0535
33293383	1675	1679	Sur1	Gene	6833
33293383	1690	1703	glibenclamide	Chemical	MESH:D005905
33293383	1726	1729	Vpr	Gene	
33293383	1781	1786	HIV-1	Species	11676
33293383	1787	1790	Vpr	Gene	
33293383	1799	1814	proinflammatory	Disease	
33293383	1880	1890	Sur1-Trpm4	Gene	6833;54795
33293383	1975	1983	patients	Species	9606
33293383	2055	2067	HIV-infected	Disease	MESH:D015658
33293383	2068	2076	patients	Species	9606
33293383	2088	2105	neuroinflammation	Disease	MESH:D000090862
33293383	2110	2123	neurotoxicity	Disease	MESH:D020258
33293383	2144	2148	HIV-	Disease	MESH:D015658
33293383	2159	2183	neurocognitive disorders	Disease	MESH:D019965
33293383	2185	2189	HAND	Disease	MESH:D016263
33293383	2228	2243	HIV-1 infection	Disease	MESH:D015658
33293383	2248	2251	Vpr	Gene	
33293383	2286	2301	proinflammatory	Disease	
33293383	2311	2331	Toll-like receptor 4	Gene	7099
33293383	2333	2337	TLR4	Gene	7099
33293383	2340	2367	tumor necrosis factor alpha	Gene	7124
33293383	2369	2378	TNF-alpha	Gene	7124
33293383	2385	2394	NF-kappaB	Gene	4790
33293383	2404	2427	sulfonylurea receptor 1	Gene	6833
33293383	2429	2433	Sur1	Gene	6833
33293383	2435	2476	transient receptor potential melastatin 4	Gene	
33293383	2478	2483	Trpm4	Gene	54795
33293383	2562	2566	Sur1	Gene	6833
33293383	2590	2603	glibenclamide	Chemical	MESH:D005905
33293383	2672	2677	HIV-1	Species	11676
33293383	2678	2681	Vpr	Gene	
33293383	2743	2756	glibenclamide	Chemical	MESH:D005905
33293383	2770	2774	HAND	Disease	MESH:D016263
33293383	Negative_Correlation	MESH:D005905	6833
33293383	Association	MESH:D009410	6833
33293383	Association	MESH:D000090862	6833
33293383	Association	MESH:D000090862	6947
33293383	Association	MESH:D009410	54795
33293383	Association	MESH:D000090862	54795
33293383	Association	MESH:D020258	6947

